varicella-zoster%20virus%20infection
VARICELLA-ZOSTER VIRUS INFECTION
Varicella, also known as chickenpox, is a self-limited benign disease caused by primary varicella-zoster virus (VZV) infection characterized by fever, malaise, and generalized pruritic vesicular rash.
The average incubation period is 14-16 days. It is transmitted via direct contact with vesicular fluid or inhalation of aerosolized respiratory secretions or via droplet route during face-to-face contact.
Hallmark sign is pruritic rash that begins in the scalp and face which eventually spreads to the trunks and extremities.
Drug Information

Indication: Vaccination against varicella in individuals ≥12 mth.

Indication: Prevention of herpes zoster (shingles) & postherpetic neuralgia; reduction of acute & chronic zoster-a...

Indication: Treatment & prevention of herpes simplex virus infections, genital herpes of skin & mucous membranes &...

Indication: HSV skin infections including initial & recurrent genital herpes labialis.

Indication: Herpes simplex virus infections of skin & mucous membranes including initial & recurrent genital herpe...

Indication: HSV skin infection including genital herpes & herpes labialis.

Indication: Herpes zoster. Accelerates the resolution of pain by reducing the duration & proportion of patients w/ zos...

Indication: Promoting resolution of acute clinical manifestations of mucocutaneous HSV infections in immunocompromised pat...

Indication: Herpes simplex skin infections including initial & recurrent labial & genital herpes simplex infection...

Dosage: Adult Herpes simplex infections 200 mg 5 times daily at 4-hrly intervals for 5 days. Severely immunocompromise

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 12 Feb 2020
Incorporating genotyping of human adenovirus (HAdV) infections in clinical practice may inform risk stratification and treatment decisions, according to a new Singapore study.
Tristan Manalac, 25 Oct 2019
Old age and lower white cell counts are significant risk factors for poor platelet recovery among dengue patients with thrombocytopaenia, according to a recent Singapore study.
14 Feb 2020
A 10-day or 14-day sequential therapy strategy is more cost-effective than a conventional triple therapy in the management of patients with Helicobacter pylori infection, in addition to being more effective in terms of eradication of infection, as reported in a study from Egypt.
Tristan Manalac, 04 Sep 2019
A booster injection of CYD-TDV (Dengvaxia) can generally restore antidengue antibody titres 5 years after a three-dose schedule, according to a new Singapore study.